American Society of Addiction Medicine

In the fall of 2020, ASAM asked its members to answer a survey on structural racism in addiction medicine. The survey probed on two main areas. The first area was racism as it affects the health professionals who treat addiction. The second area was racism as it affects patients who suffer from addiction and the care they are able to access and receive.

The American Board of Medical Specialties’ (ABMS) approval of a four-year extension of the practice pathway in Addiction Medicine. This extension will allow physicians with substantial experience in the practice of Addiction Medicine, but who have not completed an ACGME-accredited fellowship in Addiction Medicine, to apply for the Addiction Medicine certification exam through the 2025 Exam Cycle.

The Minnesota Society of Addiction Medicine (MNSAM) submitted a letter of support for SF61/HF19, companion bills which would remove the “buy and bill” requirement from all practitioner administered medications for substance use disorders (SUD).

ASAM released its 2020 Advocacy Year in Review, which provides an overview of some of the new policies and resources that ASAM and its State Chapters helped advance in 2020, by working closely with federal and state policy-makers and other key stakeholders.

The American Society of Addiction Medicine (ASAM), sent a letter to provide comments on the Interim Final Rule on the Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment (the “Interim Final Rule”).